Allogeneic Gene-Modified Tumour Cells in Metastatic Kidney Cancer. Report II
Giancarlo Pizza1, C. De Vinci1, G. Lo Conte1, A. Mazzuca1, V. Di Maio1, S. Ratini1, G. Severini1, L. Busutti2, A. P. Palareti3, A. Gulino4, A. Vacca4, L. Melchiorri5, M. Ferrari6, L. Giacomelli7, O. R. Baricordi5, S. Forzini8, R. Capanna8
1Immunotherapy Module, Operative Unit (O. U.) of Urology, Department of Urology and Nephrology, S. Orsola-Malpighi Hospital, Bologna, Italy 2O.U. of Radiotherapy, Department of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy 3Department of Computer Science, University of Bologna, Bologna, Italy 4Experimental Medicine, University "La Sapienza", Rome, Italy 5Department of Experimental and Diagnostic Medicine, Section of Medical Genetics, University of Ferrara, Ferrara, Italy 6Experimental Institute of Zooprophylaxis, Emilia-Romagna and Lombardia Regions, Brescia, Italy 7Department of Surgical Science University of Rome "La Sapienza", Rome, Italy 82nd Division of Orthopaedics and Reconstructive Surgery Centre, Florence, Italy
Received November 2004
Accepted November 2004
Crossref Cited-by Linking
Rosenblatt Jacalyn, McDermott David F.: Immunotherapy for Renal Cell Carcinoma. Hematology/Oncology Clinics of North America2011, 25, 793. <https://doi.org/10.1016/j.hoc.2011.04.010>
Sfoungaristos Stavros, Giannitsas Konstantinos, Perimenis Petros: Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma. Expert Opinion on Pharmacotherapy2011, 12, 533. <https://doi.org/10.1517/14656566.2011.524928>
Brookman-May Sabine, Burger Maximilian, Wieland Wolf F, Rößler Wolfgang, May Matthias, Denzinger Stefan: Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease. Expert Review of Vaccines2011, 10, 837. <https://doi.org/10.1586/erv.11.64>
